Literature DB >> 18073532

The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints.

Marcia A Munoz1, Darren N Saunders, Michelle J Henderson, Jennifer L Clancy, Amanda J Russell, Gillian Lehrbach, Elizabeth A Musgrove, Colin K W Watts, Robert L Sutherland.   

Abstract

The cellular response to DNA damage is critical for maintenance of genomic integrity and inhibition of tumorigenesis. Mutations or aberrant expression of the E3 ubiquitin ligase EDD have been observed in a number of carcinomas and we recently reported that EDD modulates activity of the DNA damage checkpoint kinase, CHK2. Here, we demonstrate that EDD is necessary for G(1)/S and intra S phase DNA damage checkpoint activation and for the maintenance of G(2)/M arrest after double strand DNA breaks. Defective checkpoint activation in EDD-depleted cells led to radio-resistant DNA synthesis, premature entry into mitosis, accumulation of polyploid cells, and cell death via mitotic catastrophe. In addition to decreased CHK2 activation in EDD-depleted cells, the expression of several key cell cycle mediators including Cdc25A/C and E2F1 was altered, suggesting that these checkpoint defects may be both CHK2-dependent and -independent. These data support a role for EDD in the maintenance of genomic stability, emphasising the potential importance of dysregulated EDD expression and/or function in the evolution of cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18073532     DOI: 10.4161/cc.6.24.5021

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  34 in total

1.  Effects of EDD on p53 function are context-specific.

Authors:  Colin K Watts; Darren N Saunders
Journal:  J Biol Chem       Date:  2011-07-15       Impact factor: 5.157

2.  Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.

Authors:  Tyler M MacDonald; Lynn N Thomas; Emily Daze; Paola Marignani; Penelope J Barnes; Catherine Kl Too
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

3.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

4.  Normal human cell proteins that interact with the adenovirus type 5 E1B 55kDa protein.

Authors:  George Hung; S J Flint
Journal:  Virology       Date:  2017-01-27       Impact factor: 3.616

5.  BMI1-UBR5 axis regulates transcriptional repression at damaged chromatin.

Authors:  Anthony Sanchez; Angelo De Vivo; Nadima Uprety; Jonghwan Kim; Stanley M Stevens; Younghoon Kee
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

6.  Regulation of the human papillomavirus type 18 E6/E6AP ubiquitin ligase complex by the HECT domain-containing protein EDD.

Authors:  Vjekoslav Tomaic; David Pim; Miranda Thomas; Paola Massimi; Michael P Myers; Lawrence Banks
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

7.  The novel interaction between microspherule protein Msp58 and ubiquitin E3 ligase EDD regulates cell cycle progression.

Authors:  Mario Benavides; Lai-Fong Chow-Tsang; Jinsong Zhang; Hualin Zhong
Journal:  Biochim Biophys Acta       Date:  2012-10-12

8.  Ubiquitin control of S phase: a new role for the ubiquitin conjugating enzyme, UbcH7.

Authors:  Elizabeth A Whitcomb; Allen Taylor
Journal:  Cell Div       Date:  2009-08-07       Impact factor: 5.130

9.  The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover.

Authors:  M Bohgaki; A Hakem; M J Halaby; T Bohgaki; Q Li; P A Bissey; J Shloush; T Kislinger; O Sanchez; Y Sheng; R Hakem
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

10.  Protein kinase DYRK2 is a scaffold that facilitates assembly of an E3 ligase.

Authors:  Subbareddy Maddika; Junjie Chen
Journal:  Nat Cell Biol       Date:  2009-03-15       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.